CTRI/2023/06/054147尚未招募3 期
A randomized, double blind study to evaluate the effect of integrative approach of allopathic and Ayurvedic medications in the management of chronic stable angina
Shathyu Ayurveda Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients with symptoms of angina and documented CAD by CTCA with or without prior evidence of CAD will be eligible to be enrolled into the study.
排除标准
- •Patients already listed or planning to undergo coronary angioplasty in the 6 month study period
- •Pregnant women
- •Seriously ill patients
- •Patients with psychiatric illnesses
研究者
相似试验
Unknown
2 期
To see the effect of H-009 and Arsenic-sulphuricum-flavum in color change of vitiligo white patches and examining safety in patientsCTRI/2012/03/002531Homeopathy India Private Limited
已完成
3 期
A randomized, double-blind study to evaluate the safety and effectiveness of the Exhale Drug-eluting stent in homogeneous emphysema subjects with severe hyperinflation, the EASE - study. & Local ammendment: Protocol revision to evaluate the ExhaleUltraNeedle in the EASE study.COPD10038716EmphysemaNL-OMON30701Broncus Technologies Inc.15
进行中（未招募）
不适用
A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathyEUCTR2009-012836-33-SEGlaxoSmithKline Research & Development Limited142
进行中（未招募）
不适用
A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathyeuropathic pain from lumbosacral radiculopathyMedDRA version: 12.0Level: LLTClassification code 10037779Term: RadiculopathyEUCTR2009-012836-33-DEGlaxoSmithKline Research & Development Limited142
进行中（未招募）
1 期
A randomised, double blind study to evaluate the safety andefficacy of the p38 kinase inhibitor, GW856553, in subjects withneuropathic pain from peripheral nerve injury.Estudio aleatorizado, doble ciego para evaluar la seguridad y la eficacia de GW856553, un inhibidor de la quinasa p38, en sujetos con dolor neuropático por lesión de nervio periférico.europathic painMedDRA version: 9.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2009-010091-17-ESGlaxoSmithKline Research & Development Limited